Stay updated on Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page footer revision label was updated from v3.6.5 to v3.6.6, indicating a small update to the page's revision history.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision label changed from v3.6.4 to v3.6.5. This is a minor maintenance update and does not change the study details or user-facing content.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page revision number was updated from v3.6.3 to v3.6.4, indicating a small update to the page framework rather than the study content.SummaryDifference0.0%

- Check69 days agoChange DetectedThe Publications section now includes a complete bibliographic entry for the SKYSCRAPER-06 publication (Socinski et al.), JAMA Oncol. 2026;12(6):619-627, DOI 10.1001/jamaoncol.2026.0818. The earlier Online ahead of print entry (April 30, 2026; e260818) has been removed.SummaryDifference0.0%

- Check84 days agoChange DetectedNew sections to guide users have been added ('No longer looking for participants', 'How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a new revision label v3.6.0 appears. The heading 'Intervention / Treatment' was replaced by 'Intervention/Treatment', and the prior revision label v3.5.5 was removed.SummaryDifference0.2%

- Check91 days agoChange DetectedResults have been posted for the study, and the page now notes 127 locations. The update also introduces detailed outcome definitions for progression-free survival (PFS) and overall survival (OS), along with associated measurement timelines and related data elements.SummaryDifference2%

Stay in the know with updates to Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.